skip to main content

H.R. 5800: Medicaid Institutes for Mental Disease Are Decisive in Delivering Inpatient Treatment for Individuals but Opportunities for Needed Access are Limited without Information Needed about Facility Obligations Act

The text of the bill below is as of Jun 8, 2018 (Reported by House Committee).


IB

Union Calendar No. 552

115th CONGRESS

2d Session

H. R. 5800

[Report No. 115–717]

IN THE HOUSE OF REPRESENTATIVES

May 15, 2018

(for himself and Mrs. Mimi Walters of California) introduced the following bill; which was referred to the Committee on Energy and Commerce

June 8, 2018

Additional sponsors: Mrs. Blackburn and Mr. Walden

June 8, 2018

Committed to the Committee of the Whole House on the State of the Union and ordered to be printed


A BILL

To require the Medicaid and CHIP Payment and Access Commission to conduct an exploratory study and report on requirements applicable to and practices of institutions for mental diseases under the Medicaid program.


1.

Short title

This Act may be cited as the Medicaid Institutes for Mental Disease Are Decisive in Delivering Inpatient Treatment for Individuals but Opportunities for Needed Access are Limited without Information Needed about Facility Obligations Act or the Medicaid IMD ADDITIONAL INFO Act.

2.

MACPAC exploratory study and report on institutions for mental diseases requirements and practices under Medicaid

(a)

In general

Not later than January 1, 2020, the Medicaid and CHIP Payment and Access Commission established under section 1900 of the Social Security Act (42 U.S.C. 1396) shall conduct an exploratory study, using data from a representative sample of States, and submit to Congress a report on at least the following information, with respect to services furnished to individuals enrolled under State plans under the Medicaid program under title XIX of such Act (42 U.S.C. 1396 et seq.) (or waivers of such plans) who are patients in institutions for mental diseases and for which payment is made through fee-for-service or managed care arrangements under such State plans (or waivers):

(1)

A description of such institutions for mental diseases in each such State, including at a minimum—

(A)

the number of such institutions in the State;

(B)

the facility type of such institutions in the State; and

(C)

any coverage limitations under each such State plan (or waiver) on scope, duration, or frequency of such services.

(2)

With respect to each such institution for mental diseases in each such State, a description of—

(A)

such services provided at such institution;

(B)

the process, including any timeframe, used by such institution to clinically assess and reassess such individuals; and

(C)

the discharge process used by such institution, including any care continuum of relevant services or facilities provided or used in such process.

(3)

A description of—

(A)

any Federal waiver that each such State has for such institutions and the Federal statutory authority for such waiver; and

(B)

any other Medicaid funding sources used by each such State for funding such institutions, such as supplemental payments.

(4)

A summary of State requirements (such as certification, licensure, and accreditation) applied by each such State to such institutions in order for such institutions to receive payment under the State plan (or waiver) and how each such State determines if such requirements have been met.

(5)

A summary of State standards (such as quality standards, clinical standards, and facility standards) that such institutions must meet to receive payment under such State plans (or waivers) and how each such State determines if such standards have been met.

(6)

Recommendations for actions by Congress and the Centers for Medicare & Medicaid Services. such as how State Medicaid programs may improve care and improve standards and including a recommendation for how the Centers for Medicare & Medicaid Services can improve data collection from such programs to address any gaps in information.

(b)

Stakeholder input

In carrying out subsection (a), the Medicaid and CHIP Payment and Access Commission shall seek input from State Medicaid directors and stakeholders, including at a minimum the Substance Abuse and Mental Health Services Administration, Centers for Medicare & Medicaid Services, State Medicaid officials, State mental health authorities, Medicaid beneficiary advocates, health care providers, and Medicaid managed care organizations.

(c)

Definitions

In this section:

(1)

Representative sample of States

The term representative sample of States means a non-probability sample in which at least two States are selected based on the knowledge and professional judgment of the selector.

(2)

State

The term State means each of the 50 States, the District of Columbia, and any commonwealth or territory of the United States.

(3)

Institution for mental diseases

The term institution for mental diseases has the meaning given such term in section 435.1009 of title 42, Code of Federal Regulations, or any successor regulation.

June 8, 2018

Committed to the Committee of the Whole House on the State of the Union and ordered to be printed